|[Frontiers in Bioscience 1, d146-160, August 1, 1996]|
INTERACTION OF HUMAN SPERMATOZOA WITH THE ZONA PELLUCIDA OF OOCYTE: DEVELOPMENT OF THE ACROSOME REACTION
Patricio Morales1 and Miguel Llanos2
1 P. Catholic University of Chile, Faculty of Biological Sciences. P. O. Box 114-D. Santiago, Chile.
2INTA, University of Chile, P. O. Box 138-11. Santiago, Chile.
2INTA, University of Chile, P. O. Box 138-11. Santiago, Chile.
TABLE OF CONTENTS
Mammalian spermatozoa are not able to fertilize an oocyte upon ejaculation. To gain fertilizing ability, spermatozoa must, either in vivo or in vitro, undergo a process termed capacitation. Since a reliable marker for capacitation does not exist, it is considered that this process is completed when the spermatozoa are able to undergo acrosomal exocytosis. Therefore, the AR has become one of the best studied events in the process of fertilization. Fertilization is a very complex phenomenon, involving sequential interactions between the fertilizing spermatozoon and cumulus oophorus, ZP, and oolemma. The AR may be playing a key role in penetration of spermatozoa through these egg vestments.
There is still debate about the composition of the human zona pellucida (ZP). SDS-PAGE of zona pellucida proteins under non-reducing conditions shows two to three main bands. The biological function of the individual components of ZP is just beginning to be recognized. Recombinant human ZP3 promotes the acrosome reaction and stimulates a protein with tyrosine kinase activity. Whether human zona pellucida or recombinant ZP3 can also stimulate sperm calcium influx is not known. Regarding the status of the sperm binding proteins for zona ligands, several candidates have been proposed. Among them are a galactosyltransferase, a D-mannosidase, a protein tyrosine kinase, and an unusual galactosyl receptor lectin. Clearly, the binding of the spermatozoa to the ZP triggers the acrosomal exocytosis. The mechanism (s) by which the acrosome reaction (AR) is stimulated by the ZP seems to be related to the production and sequential action of several intracellular messengers, with a crucial function in the development of the AR. It has been suggested that progesterone and the zona pellucida may synergistically act to promote acrosomal exocytosis in mouse. Whether the same is true in humans is not yet known; however, progesterone-treated human spermatozoa bind to the ZP in higher numbers than the non-treated spermatozoa. Other molecules have been recognized that serve a modulatory role in the spermatozoa-ZP binding process. The aim of the present review is to summarize the current knowledge about human spermatozoa-ZP interactions and the mechanisms accounting for the AR.
All mammalian eggs are surrounded by the ZP, an extracellular coat that is synthesized by the oocyte (1). The ZP is the site of the initial interaction of the spermatozoa with the oocyte. This interaction includes the species-specific spermatozoa-ZP binding and induction of the AR, both of which are prerequisites for successful in-vivo fertilization.
Results of cDNA cloning of the ZP genes and analysis of the composition of ZP from several different species indicate that ZP is constituted of three or four glycoproteins (2). The ZP of the mouse oocyte, one of the best studied ZP, is composed of three sulphated glycoproteins termed ZP1, ZP2 and ZP3 (1, 3). ZP1 is a homodimer (Mr= 185-200 kDa) and its chains are connected by intermolecular disulphide bonds. ZP2 (Mr= 120-140 kDa) and ZP3 (Mr= 83 kDa) form a heterodimer of long filaments with a repeating structure (1, 3). ZP1 provides a structural integrity for the ZP by cross-linking the ZP2/ZP3 filaments. Only ZP2 and ZP3 have been shown to possess biological functions. ZP3 mediates the initial binding of acrosome-intact spermatozoa to the ZP via O-linked side chains (4, 5). Following sperm binding, ZP3 induces the AR in the bound spermatozoa (6). The acrosome-reacted spermatozoa, which can no longer interact with ZP3, bind to ZP2 (7) and penetrate through the ZP. After fertilization, there are molecular changes in ZP2 and ZP3 that constitute a block to polyspermy. ZP3 is converted to a form called ZP3f, which no longer binds acrosome-intact spermatozoa and is incapable to induce the AR (6). Since O-linked carbohydrates are implicated in interaction of ZP3 with spermatozoa and there is no apparent change in the electrophoretic mobility of ZP3f (6, 8), this change in ZP3 is thought to be caused by a cortical granule-released glycosidase (9). ZP2 is converted to a form called ZP2f that no longer interacts with acrosome-reacted spermatozoa (10). ZP2 is cleaved by a protease from the cortical granules (11) and is detected by a shift in its electrophoretic mobility (from Mr= 120 kDa to Mr= 90 kDa) under reducing conditions (12).
In contrast to these findings in the mouse, there are only a few reports regarding the composition of the human ZP (13-17). Shabanowitz and colleagues reported only two components (Mr= 90-110 kDa and Mr= 57-73 kDa) under nonreducing conditions and three components (Mr= 90-110 kDa, Mr= 65-78 kDa, and Mr= 57-73 kDa) under reducing conditions (16, 17). They termed these proteins ZP1, ZP2 and ZP3, respectively. A ZP component corresponding to the mouse ZP1 (Mr= 200 kDa) was not detected. Similarly, under reducing conditions Bercegeay et al. found protein components of 80-92 kDa, 58-66 kDa, and 54-72 kDa (13). Based upon their molecular weight these components could correspond to mouse ZP2 and ZP3, respectively. Naz and Ahmad showed that the human ZP analyzed under non-reducing conditions exhibited 3 major protein bands of 220, 110 and 55 kDa. The ZP protein that reacted strongest with the sperm proteins was the 55 kDa molecular region (ZP3) (15). Recently, Moos et al. using a non-radioactive biotinylation- and a lectin-based detection system found that, under non-reducing conditions, the human ZP of unfertilized eggs is composed of three glycoprotein species designated as ZP1 (Mr~150 kDa), ZP2 (Mr~100 kDa) and ZP3 (Mr~55-65 kDa) (14).
In all the above studies, ZP1 was not detected after fertilization. In contrast, in the mouse ZP1 is present and is apparently unaltered following fertilization (12). Therefore, it has been suggested that in humans, the cortical granule-derived proteases may degrade ZP1 to forms that are not detectable by electrophoresis (14).
As indicated, the glycoprotein composition of the ZP from several mammalian species has been well elucidated (18, 19). However, only limited information exists regarding the molecular identities and biochemical characteristics of the sperm surface components involved in zona binding. Several glycoprotein candidates have been proposed over the past years, among them are:
Galactosyltransferase is an enzyme located within the plasma membrane of spermatozoa that has a defined role in gamete recognition in the mouse (20). This enzyme mediates sperm-egg recognition by binding to N-acetylglucosamine residues on ZP glycoconjugates. Recently, the mouse zona protein ZP3 was identified as the complementary binding site for interaction with sperm ß-1,4-galactosyltransferase. This interaction mediates tight spermatozoa-ZP binding (21). A potential role of multivalent binding between ZP3 and several galactosyltransferase moieties in the induction of the AR has been proposed (21). This enzyme, however, may not be present in human spermatozoa (22).
Human spermatozoa possess a D-mannosidase activity (22) which may be involved in binding to ZP3 and induction of the AR (23). The sugar moieties involved in these processes are mannose-rich oligosaccharides on zona glycoconjugates (22). A positive relationship has been demonstrated between the appearance of mannose-binding sites on the surface of human spermatozoa and the outcome of in vitro fertilization (24). Previous studies, however, have failed to demonstrate inhibition of spermatozoa-ZP binding by treating the spermatozoa with mannose (25, 26) (see table 1).
* Sperm aliquots treated for 30 min with 50 mmoles/l of D-mannose were use to inseminate single oocytes for 6 hr. Control spermatozoa were incubated with medium alone. Modified from (25 and 26).
One class of molecule that could account for both ZP3 recognition and signal transduction is a receptor tyrosine kinase (27). Exposure of both mouse and human spermatozoa to ZP3 results in the rapid autophosphorylation of tyrosine residues on the putative, 95 kDa, zona receptor kinase (ZRK). Using a monoclonal antibody directed against ZRK to screen a human testicular complementary DNA library, Burks et al. isolated a full-length clone predicting a 600 amino acid receptor that contains a unique cysteine-rich extracellular domain (28). Peptides from the extracellular domain of this molecule suppress spermatozoa-zona binding. Recently, Saling and colleagues reported that recombinant human ZP3 (hZP3rec), expressed in COS cells, stimulates tyrosine phosphorylation of human ZRK, in vivo and in vitro (29). Tyrphostin, a tyrosine phosphorylation inhibitor, inhibited the AR induced by hZP3rec (29). These results suggest that human ZRK is a receptor for human ZP3 and that ligand-stimulated tyrosine kinase activity in human spermatozoa is essential for the signaling cascade regulating exocytosis of the sperm acrosome. However, the 95 kDa phosphotyrosine-containing protein found in the mouse spermatozoa has been shown to be a unique form of phosphorylated hexokinase (30).
Naz and Ahmad reported on several sperm proteins that have the capacity to bind ZP proteins with molecular weights of 95, 63, 51 and 14-18 kDa (15). These proteins showed autophosphorylating activity. Potentially, the 95 kDa protein corresponds to the ZRK described by Saling and colleagues (28).
An unusual galactosyl receptor, C-type (Ca2+-dependent) lectin on human spermatozoa may be the zona receptor (31, 32). This lectin is a transmembrane protein with carbohydrate-recognition domains on the C-terminal extracellular segment and an N-terminal cytoplasmic anchor. This protein was characterized as a single protein component of 50 kDa confined to the plasma membrane of the head of the spermatozoa overlying the acrosome (32).
As was discussed above, work from several laboratories has revealed presence of multiple ZP3 binding proteins/receptors on the sperm cell. Therefore, it is quite possible that multiple sperm binding proteins/receptors could all be involved in mediating the biological actions of ZP3, the primary sperm binding, and induction of the AR. This multiple interactive capacity could be due to different specialized domains in ZP3, which all face the sperm head surface. Each of these domains could be structurally adequate (or specialized) to interact and/or activate a particular sperm binding protein/receptor, to permit binding of spermatozoa to the ZP3, and to subsequently induce production of intracellular second messengers that lead to AR. It is also possible that ZP3 interacts and activates one type of sperm receptor with the subsequent activation of other receptor (s) (33). Interaction of ZP3 with the sperm surface may occur in a multivalent fashion. Thus, different sperm binding proteins/receptors could, together, constitute a functional ZP3 receptor signal-transduction complex that is capable of transducing intracellular signals to modulate the AR (33).
In human, the candidate receptors for the ZP with a role in the AR are: a 95-kDa protein with characteristics of a protein tyrosine kinase termed zona receptor kinase (ZRK) (28) and a 51 Kd protein, that is also a tyrosine kinase and which subsequently was recognized as the human FA-1 antigen (34, 35). A role for a sperm glycine receptor/Cl- channel in the ZP initiated AR has also recently been suggested (36).
ZP is involved in several essential events in fertilization of mammalian eggs. This includes species-specific sperm recognition and binding, stimulation of the sperm AR, and the egg-induced block to polyspermy. All these events are specially well documented in the mouse (1, 3). Since only acrosome-reacted spermatozoa are capable of penetrating through the ZP and fusing with the egg plasma membrane, the AR is crucial for successful fertilization of eggs in mammals (37).
The morphological characteristics of the AR in human spermatozoa are similar to that of other mammalian species investigated thus far (38). AR implies a sequential process of fusion and fenestration of the outer acrosomal membrane and its overlying plasma membrane, which permits release of soluble contents of acrosome and apparently facilitates the passage of spermatozoa through the ZP. A subsequent formation of mixed vesicles, composed of outer acrosomal membrane and plasma membrane, occurs. These vesicles remain close to the sperm head for a short time and then disperse. Since only acrosome-reacted spermatozoa penetrate the zona, the inner acrosomal membrane and the associated hydrolytic enzymes (11, 39) together with the hyperactivated motility (37, 40) should play important functions in the penetration process.
AR of human spermatozoa may be initiated by different molecules that can be classified as physiological or pharmacological inducers of this event. Within the pharmacological inducers, the most extensively used agents are the calcium ionophores A23187 and ionomycin. Fusogenic compounds such as lysophospholipids have also been reported to stimulate the AR in mammalian, including human spermatozoa (41-43). The preovulatory human follicular fluid (hFF; (44)) and the human ZP (45) are considered to be among the physiological stimuli for the AR in human spermatozoa. Furthermore, the human cumulus oophorus, the human mural granulosa cells and the progestins progesterone (P) and 17-alpha-P also stimulate AR (44, 46, 47). The AR-inducing activity of hFF and cumulus oophorus is, in part, related to their P content. Indeed, individual hFF samples exhibited great differences in their ability to induce the AR and this ability was significantly correlated with the P content of each fluid (48). Moreover, charcoal-dextran treated hFF lost the AR-initiating ability, which could be only restored after re-addition of P (48). The cumulus cells may be an additional source of P. P level in the cumulus has been estimated at 1-2 µg/ml (49), which is sufficient for induction of AR.
Extensive work has been performed to elucidate the molecules and mechanisms involved in the P-induced human sperm AR (for reviews see (50, 51)). There are some similarities between the way P and the ZP induce the AR. Effects of P on the human spermatozoa are mediated by the presence of binding proteins/receptors located on the acrosomal area of a sperm subpopulation (52, 53). P acts on the human sperm surface to induce at least three different events: i) opening of a plasma membrane Ca2+ channel to induce Ca2+ influx (54, 55). This, in turns, provokes a transient, protein kinase C (PKC)-dependent elevation of intracellular free Ca2+ concentration (56); ii) opening of a plasma membrane Cl- channel to induce Cl- efflux (57). This channel appears to be part of a receptor resembling, but no identical to, the neuronal g-aminobutyric acid receptor type A (GABAA) (58); and iii) activation of a protein tyrosine kinase (59, 60). All these events seem to be due to independent actions of the steroid and are perhaps mediated by three different binding receptors (61). Thus, P may interact with a multireceptor system rather than a single receptor on the plasma membrane of spermatozoa. This hypothesis can explain the variety of responses due to nongenomic action of steroids, and reconcile experimental results that seem contradictory at the first glance (61).
The site where the fertilizing spermatozoon undergoes the AR in vivo is still a matter of debate. In the mouse, only acrosome-intact spermatozoa are able to bind to the ZP and, therefore, the fertilizing spermatozoon is presumed to undergo the AR on the zona surface (62). However, in several species, both acrosome-intact and acrosome-reacted spermatozoa are equally able to bind to the surface of the ZP and penetrate through it (63, 64). Acrosome-reacted human spermatozoa are also able to bind to the human ZP (65). However, it is yet not clear whether they are able to penetrate the ZP and fertilize the oocyte.
Studies on the effect of the ZP on sperm function have been carried out with intact and solubilized ZP and the purified glycoproteins, especially ZP3. More recently, some studies on human spermatozoa have demonstrated that a recombinant human ZP3 is able to promote the AR (29, 66). Also, acrosome-intact mouse spermatozoa are able to bind to ZP3 covalently linked to silica beads; such bound spermatozoa, subsequently, undergo AR and are released from the beads (67). Spermatozoa do not bind to silica beads to which a variety of other glycoproteins, including other zona glycoproteins, are covalently linked. The properties and mode of action of solubilized and purified ZP3 or recombinant ZP3, however, may not be necessarily identical to those of ZP3 immobilized on a three dimensional extracellular matrix. The ordered cross-linking of ZP2/ZP3 heterodimers by ZP1 generates the presence of stereospecific domains. These domains could be playing a role in mediating the effects of ZP3 on the sperm function. Their effects may not be apparent in studies using solubilized or purified ZP components.
A major shortcoming in the study of spermatozoa-oocyte interaction in humans is the scarcity of ZP material. Since the electrophoretic pattern of the ZP isolated from unfertilized eggs is identical to that of non-inseminated eggs, this has been overcome by the use of inseminated but unfertilized eggs (16). Using this biological material, it was demonstrated that the human ZP-induced AR is mediated by a sperm Gi protein (68, 69). This is also true for the murine and bovine ZP-induced AR (70, 71). Thus, after the spermatozoa bind to the ZP, a Gi protein may be a crucial transducing signal. Activation of a Gi protein mediates the production of intracellular signal (s) involved in the molecular and cellular events of the AR. In cells other than spermatozoa, Gi proteins are involved in receptor-mediated regulation of: inward rectifying K+ channels, Ca2+ mobilization, phospholipase C activity, and adenyl cyclase activity (72). Several of these processes have already been implicated in the mechanism that triggers the AR (73).
An extracellular Ca2+-dependent increase in the concentration of free intracellular Ca2+ is usually required for the initiation of the AR. This seems to be true at least for the mouse and bovine ZP-induced AR (71, 74). Pertussis toxin inhibits the ZP/ZP3 induced elevations of intracellular Ca2+ (71, 75), suggesting the involvement of a Gi protein in these events. Working with bovine spermatozoa, Florman et al. proposed a model which explains the Gi-dependent Ca2+ influx promoted by ZP/ZP3 after interaction with its sperm receptor (76). Briefly, this model states that ZP/ZP3 stimulates: i) a poorly selective, Gi protein-insensitive cation channel responsible for membrane depolarization and ii) a Gi protein-dependent alkalinization of the sperm cytoplasm. These changes activate an L-type voltage-sensitive Ca2+ channel which, in turn, causes the massive Ca2+ influx necessary for the AR (76).
The relative contribution of intracellular sources of Ca2+, however, has not been properly evaluated. There is increasing evidence for the presence of Ca2+ stores within spermatozoa which may have a role in the AR. In several somatic cells, Ca2+ found in the endoplasmic reticulum can be released by thapsigargin, a plant-derived sesquiterpene lactone that is a highly specific inhibitor of the Ca2+-ATPase responsible for Ca2+ accumulation by that organelle (77, 78). Thapsigargin stimulates the AR of capacitated human (79), mouse (80), and hamster spermatozoa (81) and it requires external Ca2+ and influx of this ion (79, 81). Thus, the Ca2+ release from intracellular stores by thapsigargin may lead to an influx of extracellular Ca2+ and subsequently to the AR. Putative sites for thapsigargin-sensitive intracellular Ca2+ stores in the spermatozoa may include the cytoplasmic droplet, the sperm nucleus and the acrosome (79, 80).
Recently, the selective localization of inositol 1,4,5-trisphosphate receptors (IP3R) in the acrosomes of rat, mouse, hamster and dog spermatozoa was reported (80). The authors also described the presence of Galphaq/11 and phospholipase Cß1, and suggested a role for inositol 4,5-trisphosphate- (IP3) gated Ca2+ release in the mammalian sperm AR. Walensky and Snyder presented a model where a multivalent interaction between ZP/ZP3 and sperm plasma membrane binding proteins/receptors leads to the production of multiple intracellular signals (80). Receptor activation of Gq (a pertussis toxin-insensitive process) leads to activation of phospholipase Cß1 with the subsequent hydrolysis of phosphatydilinositol 4,5-trisphosphate and the generation of IP3 and diacylglycerol (DAG). Then, the binding of IP3 to IP3R localized in the outer acrosomal membrane would induce the release of acrosomal Ca2+. A subsequent capacitative Ca2+ entry, through focal voltage-insensitive channels, would produce a further elevation of intracytoplasmic Ca2+, triggering membrane depolarization and activation of voltage-sensitive L-type Ca2+ channels (80). The high intracellular free Ca2+ concentration together with DAG production would be required for molecular events leading to membrane fusion and finally for the acrosomal exocytosis (82-84).
Hydrolysis of polyphosphoinositides could be involved in the ZP-induced AR. Hydrolysis of polyphosphoinositides produces IP3 and DAG, both of which are involved in the AR as stated above. Polyphosphoinositides are constituted by phosphatydilinositol, phosphatydilinositol 4-phosphate and phosphatydilinositol 4,5-bisphosphate. In mammalian spermatozoa, polyphosphoinositides seem to be located in the inner and outer leaflets of the plasma and outer acrosomal membranes, respectively (85). In the classic model, IP3 and DAG produced after hydrolysis of phosphatydilinositol 4,5-bisphosphate by a phospholipase C are involved in modulation of intracellular Ca2+ concentration and activation of a PKC (86). In several mammalian spermatozoa, including human, the activation of PKC (a molecule able to phosphorylate proteins) is involved in the AR (87, 88). Besides the activation of PKC, DAG produced in the spermatozoa activates a phospholipase C, able to hydrolyze phosphatydilcholine and to further increase the level of DAG (84). This high level of DAG would modulate a phospholipase A2 (PLA2) (82, 83). This key enzyme, which produces fusogenic compounds such as lysophospholipids and free fatty acids, is required for the development of AR (41, 42, 89).
The role of ZP in the hydrolysis of polyphosphoinositides in human spermatozoa is not known. However, in mouse spermatozoa, stimulation with ZP or P results in hydrolysis of phosphatydilinositol 4-phosphate and phosphatydilinositol 4,5-bisphosphate (84). Recently, it was reported that mouse ZP/ZP3 activates a phosphatydilinositol 4,5-bisphosphate-PLCgamma1 through a mechanism involving tyrosine phosphorylation (90). In human spermatozoa, a fraction of hFF induces hydrolysis of polyphosphoinositides that rely upon a primary Ca2+ entry (91). This may contradict the model proposed by Walensky and Snyder (80), in which Ca2+ influx occurs subsequent to and is stimulated by the mobilization of internal Ca2+. Early events of the AR require micromolar Ca2+ levels whereas later events require millimolar levels of Ca2+ (82, 92). Those findings suggest that the small, rapid, and IP3-dependent Ca2+ increase is due to intracellular Ca2+ mobilization, and that this is followed by extracellular Ca2+ influx.
Phosphodiesterase inhibitors and analogs of cAMP stimulate the AR (73). Activators of the protein kinase A pathway (PKA), such as forskolin and dibutiryl cAMP, also induce the AR of capacitated human spermatozoa (93). In addition, the hFF-induced and solubilized human ZP-induced AR are blocked by KT5720, which is an inhibitor of PKA (93). PKA inhibitors prevent the stimulation of the AR by a PKC stimulator and vice-versa (94). De Jonge suggested that a cross talk between the PKA and PKC pathways may lead to phosphorylation of proteins followed by AR (94).
An elevation of cAMP was observed during the ZP-induced mouse sperm AR (95), indicating that ZP modulates the activity of adenylyl cyclase (AC). Lecler and Kopf reported that ZP and forskolin, in a concentration dependent manner and in the presence of Mg2+, but not Mn2+, can stimulate a membrane associated AC in capacitated mouse spermatozoa (96). Forskolin (a stimulator of the AC) has been also reported to induce the human sperm AR, an effect that can be blocked by adenosine analogs known to inhibit AC. The latter blockage is inhibited by cAMP analogs, suggesting that forskolin acts through AC (93). Though several G proteins are present in mammalian spermatozoa, the presence of a Gs protein in these cells has not yet been documented (97). Therefore, it is not clear as how the sperm AC is activated. Further investigation is needed to elucidate the mechanism (s) by which ZP stimulates the membrane-associated AC and to reveal its role in the AR. A link between AC activation, increased cAMP concentration, Ca2+ channel modulation, and the development of the AR were recently suggested (96).
Solubilized ZP stimulates a protein tyrosine kinase activity involved in the mouse sperm AR. A 95 kDa protein, found on the sperm surface, was suggested to bind ZP3, possesses tyrosine kinase activity and participates in the AR (98, 99). The role of this protein as a ZP3 receptor in the mouse, however, should be re-examined, since it was demonstrated that this protein is indeed a unique, phosphotyrosine-containing form of hexokinase, only found in the testis and spermatozoa (30). It was shown that a 95 kDa protein in the human spermatozoa interacts with human ZP (ZRK; distinct from hexokinase) and that this protein contains phosphotyrosine and tyrosine kinase activity. Moreover, recombinant human ZP3, obtained from human ZP3 cDNA transfected COS cells, stimulates kinase activity (28). In addition, in capacitated human spermatozoa, tyrphostin prevents the human ZP3-induced AR (29). Taken together, these results indicate that ZP3-induced tyrosine phosphorylation of ZRK coincides with the ZP3-induced AR, strongly suggesting a direct role for the tyrosine kinase activity in the AR of human spermatozoa. The function of tyrosine phosphorylation in the AR is still obscure. A recent report showed modulation of mouse sperm phospholipase C activity by ZP-stimulated tyrosine phosphorylation, linking the protein tyrosine kinase signaling pathway and phosphatydilinositol 4,5-bisphosphate hydrolysis (90). As discussed above, this pathway seems to play a crucial role in the AR.
Several investigators have proposed a role for an endogenous trypsin-like activity in the mechanism of the mammalian sperm AR (100). This trypsin-like activity may be involved in the dispersal of the acrosomal matrix, the membrane events of the AR or both (101, 102). In human, the AR induced by the human ZP and FF is inhibited by several trypsin inhibitors (103). These results suggest that hFF and human ZP induce the human sperm AR through a common mechanism mediated by a trypsin-like protease activity. A chymotrypsin-like activity is also involved in the human ZP- and hFF-induced sperm AR (100). The precise role of this chymotrypsin-like activity, however, remains to be elucidated. In sea urchin spermatozoa, a chymotrypsin-like enzyme is involved in the activation of Ca2+ channels and leads to an increase in the level of intracellular Ca2+, a crucial requisite for the AR (104). The hFF-induced AR also induces a rapid and transient increase in the level of intracellular Ca2+ due to Ca2+ influx (54, 55). This event can be inhibited by trypsin and chymotrypsin inhibitors (105, 106), suggesting a role for both types of protease activity in the elevation of intracellular Ca2+ level. In the mouse and bovine spermatozoa, the ZP-induced AR is associated with a Ca2+ influx (71, 74). Therefore, it could be speculated that the effect of trypsin and chymotrypsin inhibitors on the human ZP-induced AR (100, 103) may be due to an inhibition of the ZP-stimulated Ca2+ influx before the induction of the AR. Further research is required to clarify the identity and possible role of these trypsin and chymotrypsin-like activities in the human sperm AR.
In response to an oocyte-derived signal or signals, at the time of fertilization of the oocyte, the spermatozoon undergoes acrosomal exocytosis (37). The generally accepted view is that the fertilizing spermatozoon traverses the cumulus oophorus using the hyaluronidase activity present in the protein PH20, located on the plasma membrane of the posterior head (107). Then, the fertilizing spermatozoon, with its acrosome-intact, binds to the zona pellucida glycoprotein, ZP3. Following stimulation by ZP3, the spermatozoon undergoes the AR. Exposure to ZP3 leads to tyrosine phosphorylation of a 95 kDa protein (15, 28, 29) and activation of a guanosine triphosphate (GTP)-binding protein (68). Progesterone (P) trapped in or produced by the cumulus oophorus can also initiate the AR (46). P action is specific (54, 58), is mediated by a surface receptor (108), and leads to phosphorylation of a 95 kDa protein (60). G protein activation, however, does not take place (109).
Interaction between P and the ZP has been reported in the mouse (110). During sperm activation, both agonists sequentially interact. As compared with simultaneous presence of both P and ZP or presence of agonists in the reverse order, spermatozoa treated sequentially with half maximal concentrations of P and ZP exhibited enhanced exocytosis (110). Based on these findings, it was concluded that P exerts a priming effect in the initiation of the AR. Whether a similar interaction between P and ZP takes place during human fertilization is not known. Regarding spermatozoa-ZP binding, P may (111) or may not (112) increase the total number of spermatozoa able to bind to the ZP. Recent experiments conducted in our laboratory have shown that P definitively increases the number of zona bound spermatozoa. Treatment of the spermatozoa with P (1 µg/ml) caused a significant increased (292±25%) in their capacity to bind to the ZP. This effect required presence of calcium in the culture medium (Morales and Llanos, unpublished results).
Fucoidin is a heteropolisaccharide consisting primarily of alpha(1'2)- and ß(1'3)-linked L-fucose sulfate subunits. Treatment of the spermatozoa with fucoidin inhibits spermatozoa-ZP binding in humans (113). The specificity of the fucoidin, however, is ambiguous since incubation of ZP with fucoidin also caused inhibition of spermatozoa-zona binding (113).
Removal of sialic acid may also play an important role in spermatozoa-zona binding since treatment of the spermatozoa with neuraminidase, an enzyme that cleaves alpha(2-->3)- or ß(2-->8)-linked sialic acid residues, enhanced attachment of spermatozoa to the human ZP (114). Removal of sialic acid from the sperm surface is associated with loss of net negative charges (115) and sperm capacitation (116).
Previous studies have attributed a role to the sperm mannose-binding sites on the spermatozoa-ZP binding process (24-26, 117). However, Mori and colleagues observed only a 50% decrease in the number of spermatozoa bound to the ZP even at the highest mannose concentration tested (50 mmol/l) (25, 26). Zona penetration was completely inhibited (table I). A 30% inhibition of spermatozoa-ZP binding by mannose was observed by Oehninger et al. (118). Chen et al. found that treatment of the spermatozoa with mannose caused a 70% inhibition of spermatozoa-ZP binding (117). Inhibition of binding, however, was not observed during the initial phase of the spermatozoa-ZP interaction. Acrosin is one of the candidates to support binding of acrosome-reacted spermatozoa to ZP (119, 120). The action of human acrosin is inhibited by a variety of monosaccharides, especially D-fructose and D-mannose (121). Based on these observations, the data presented above can be reinterpret as follows. Mannose-treated spermatozoa can initiate binding to the human ZP followed by development of AR in the spermatozoa bound to the zona surface. Since acrosin activity is inhibited after AR, spermatozoa cannot perforate a path through the zona and such spermatozoa eventually detach from ZP.
Egg yolk and milk were recently suggested to increase the number of spermatozoa that bind to the human ZP (122, 123). The mechanism of action and the biological significance of these observations are not yet clear.
Recently, it was reported that human placental protein 14, a glycoprotein synthesized and secreted by the endometrial cells, significantly reduced spermatozoa-zona binding (124). This effect was specific for this protein and not for other endometrial stromal products. Since placental protein 14 is also expressed in ectopic endometrium (125), the authors suggested that this may provide a mechanism for endometriosis-related infertility (124).
Some recent reports have indicated that GnRH and analogs (agonists and antagonists) may modulate spermatozoa-ZP binding in humans (126, 127). GnRH is a decapeptide of hypothalamic origin which causes the release of LH and FSH from the pituitary. GnRH or GnRH-like molecules have been detected in hFF (128) and human seminal plasma (129, 130). These molecules are probably synthesized in the gonads (131-134) and in the prostate (135).
Treatment of the spermatozoa with 20 nM GnRH for 5 min increased, by 357±14%, the number of zona bound spermatozoa in comparison to the control, saline treated spermatozoa (126). Busereline, a GnRH agonist, increased the binding by 326±32%. Treatment of the spermatozoa with the GnRH antagonist 4pF (20 nM) did not cause any significant change in the number of zona-bound spermatozoa. However, 4pF administered 5 min before the addition of GnRH completely blocked the stimulatory effect of GnRH. Treatment of the spermatozoa with GnRH does not modify the percentage of acrosome reactions or the pattern of sperm movement (126).
The above findings suggest that the spermatozoa may interact with GnRH, or GnRH-like molecules at different steps during the reproductive process: 1) during spermatogenesis by local, intratesticular production (136-139); 2) during sperm maturation in the epididymis; 3) during ejaculation, upon mixing with seminal plasma (129, 130, 135); and 4) during the ascent to the site of fertilization in the ampulla of the oviduct. In the oviduct, the spermatozoa may interact with GnRH secreted locally or transported by the products of ovulation (follicular fluid, granulose cells) from the ovary (128, 131, 133).
There are still many unanswered questions regarding mammalian sperm interaction with the oocyte. The requirement for sperm capacitation as well as the acrosomal status of the spermatozoa traveling through the cumulus oophorus needs to be studied further. Although efforts have been made to establish the characteristics of the proteins present in the sperm surface which act as the receptor for ZP3 glycoprotein, the exact function for these proteins in the mechanism associated to the ZP3-induced AR has not yet been elucidated. Thus, future studies should focus on determining the exact nature of these receptors, their structure, and function. The presence of neuronal receptors (such as GABA-like and glycine receptor) in mammalian spermatozoa with a role in the AR, either induced by progesterone or solubilized ZP, has been recently suggested. In addition, the AR, a major regulatory event for mammalian spermatozoa-oocyte interaction leading to fertilization, requires further studies to integrate the information regarding the role of the different signaling pathways. These studies may provide the precise sequential role of the intracellular messengers produced after the spermatozoa-ZP interaction has taken place. If previously reacted spermatozoa can initiate binding to the ZP, one major question is whether they are able to penetrate the ZP and fertilize the oocyte. The nature of the zona (ZP2) receptor in the acrosomal-reacted spermatozoa and the acrosomal proteases in the development of the AR and penetration through the ZP need to be clarified. Investigation of these and other related questions should unravel the molecular processes involved in the acrosome reaction.
1. P. M. Wassarman: Zona pellucida glycoproteins. Ann Rev Biochem 57, 414-442 (1988).
2. O. Epifano & J. Dean: Biology and structure of the zona pellucida: a target for immunocontraception. Reprod Fertil Dev 6, 319-330 (1994).
3. P. M. Wassarman: Profile of a mammalian sperm receptor. Development 198, 1-17 (1990).
4. H. M. Florman & P. M. Wassarman: O-Linked oligosaccharides of mouse egg ZP3 account for its sperm receptor activity. Cell 41, 313-324 (1985).
5. T. K. Rosiere & P. M. Wassarman: Identification of a region mouse zona pellucida glycoprotein mZP3 that possesses sperm receptor activity. Dev Biol 154, 309-317 (1992).
6. J. D. Bleil & P. M. Wassarman: Sperm-egg interactions in the mouse: sequence of events and induction of the acrosome reaction by a zona pellucida glycoprotein. Dev Biol 95, 317-324 (1983).
7. J. D. Bleil, J. M. Greve & P. M. Wassarman: Identification of a secondary sperm receptor in the mouse egg zona pellucida: role for maintenance of binding of acrosome reacted sperm to eggs. Dev Biol 128, 376-385 (1988).
8. J.D. Bleil & P. M. Wassarman: Mammalian sperm-egg interaction: Identification of a glycoprotein in mouse egg zonae pellucidae possessing receptor activity for sperm. Cell 20, 873-882 (1980).
9. D. J. Miller, X. Gong, G. Decker & B. D. Shur: Egg cortical granule N-acetylglucosaminidase is required for the mouse zona block to polyspermy. J Cell Biol 123, 1431-1440 (1993).
10. J. D. Bleil & P. M. Wassarman: Autoradiographic visualization of the mouse egg's sperm receptor bound to sperm. J Cell Biol 102, 1393-1371 (1986).
11. C. C. Moller & P. M. Wassarman: Characterization of a proteinase that cleaves zona pellucida glycoprotein ZP2 following activation of mouse eggs. Dev Biol 132, 103-112 (1989).
12. J. D. Bleil, C. E. Beoll & P. M. Wassarman: Mammalian sperm-egg interaction: fertilization of mouse eggs triggers modification of the major zona pellucide glycoprotein, ZP2. Dev Biol 86, 189-197 (1981).
13. S. Bercegeay, M. Jean, H. Lucas & P. Barriere: Composition of human zona pellucida as revealed by SDS-PAGE after silver staining. Mol Reprod Dev 41, 355-359 (1995).
14. J. Moos, D. Faundes, G. S. Kopf & R. M. Schultz: Composition of the human zona pellucida and modifications following fertilization. Hum Reprod 10, 2467-2471 (1995).
15. R. K. Naz & K. Ahmad: Molecular identities of human sperm proteins that bind human zona pellucida: nature of sperm-zona interaction, tyrosine kinase activity, and involvement of FA-1. Mol Reprod Dev 39, 397-408 (1994).
16. R. B. Shabanowitz & M. G. O'Rand: Characterization of the human zona pellucida from fertilized and unfertilized eggs. J Reprod Fert 82, 151-161 (1988).
17. R. B. Shabanowitz: Mouse antibodies to human zona pellucida: evidence that human ZP3 is strongly immunogenic and contains two distinct isomer chains. Biol Reprod 43, 260-270 (1990).
18. M. J. Ringuette, D. A. Sobieski, S. M. Chamow & J. Dean: Oocyte-specific gene expression: Molecular characterization of a cDNA coding ZP3, the sperm receptor of the mouse zona pellucida. Proc Natl Acad Sci USA 83, 4341-4345. (1986).
19. E. C. Yurewicz, A. G. Sacco & M. G. Subramanian: Structural characterization of the Mr= 55,000 antigen (ZP3) of porcine zona pellucida. J Biol Chem 262, 564-571 (1987).
20. B. D. Shur & C. A. Neely: Plasma membrane association, purification and partial chracterization of mouse sperm B-1,4-galactosyltransferase. J Biol Chem 263, 17706-17714 (1988).
21. D. J. Miller, M. B. Maceck & B. D. Shur: Complementarity between sperm surface B-1,4-galactosyltransferase and egg-coat ZP3 mediates sperm-egg binding. Nature 357, 589 (1992).
22. D. R. P. Tulsiani, M. D. Skudlarek & M.-C. Orgebin-Crist: Human sperm plasma membrane possess alpha-D-mannosidase activity but no galactosyltransferase activity. Biol Reprod 42, 42:843-858 (1990).
23. S. Benoff, J. I. Rushbrook, I. R. Hurley, F. S. Mandel, M. Barcia, G. W. Cooper & A. Hershlag: Co-expression of mannose-ligand and non-nuclear progesterone receptors on motile human sperm identifies an acrosome-reaction inducible subpopulation. Am J Reprod Immunol 34, 100-115 (1995).
24. S. Benoff, I. R. Hurley, G. W. Cooper, F. S. Mandel, D. L. Rosenfeld & A. Hershlag: Head-specific mannose ligand receptor expression in human spermatozoa is dependent on capacitation-associated membrane cholesterol loss. Hum Reprod 8, 2141-2154 (1993).
25. K. Mori, T. Daitoh, M. Irahara, M. Kamada & T. Aono: Significance of D-mannose as a sperm receptor site on the zona pellucida in human fertilization. Am J Obstet Gynecol 161, 207-211 (1989).
26. K. Mori, T. Daitoh, M. Kamada, N. Maeda, M. Maegawa, K. Hirano, M. Irahara & T. Aono: Blocking of human fertilization by carbohydrates. Hum Reprod 8, 1729-32 (1993).
27. L. Leyton & P. M. Saling: 95 kd sperm proteins bind ZP3 and serve as tyrosine kinase substrates in response to zona binding. Cell 57, 1123-1130 (1989).
28. D. J. Burks, R. Carballada, H. D. Moore & P. M. Saling: Interaction of a tyrosine kinase from human sperm with the zona pellucida at fertilization. Science 269, 83-6 (1995).
29. D. J. Burks, S. B. McLeskey, P. Morales & P. M. Saling: Recombinant human ZP3 activates human serm ZRK. Submitted , (1996).
30. P. Kalab, P. Visconti, P. Leclerc & G. S. Kopf: p95, the major phosphotyrosine-containing protein in mouse spermatozoa, is a form of hexokinase with unique properties. J Biol Chem 269, 3810-3817 (1994).
31. M. Abdullah, E. E. Widgren & M. G. O'Rand: A mammalian sperm lectin related to rat hepatocyte lectin-2/3. Mol Cell Biochem 103, 155-161 (1991).
32. E. T. Goluboff, J. R. Mertz, L. L. Tres & A. L. Kierszenbaum: Galactosyl receptor in human testis and sperm is antigenically related to the minor C-type (Ca2+ dependent) lectin variant of human and rat liver. Mol Reprod Dev 40, 460-466 (1995).
33. G. S. Kopf, P. E. Visconti, J. Moos, H. L. Galentino-Homer & X. P. Ning. Integration of tyrosine kinase and G protein-mediated signal transduction pathways in the regulation of mammalian sperm functions. In: Human Sperm Acrosome Reaction. Eds: Fenichel P, Parinaud J, Colloque INSERM/John Libbey Eurotext Ltd., Collioure, France, 191-216 (1995).
34. P. Kaplan & R. K. Naz: The fertilization antigen-1 does not have proteolytic/acrosin activity, but its monoclonal antibody inhibits sperm capacitation and acrosome reaction. Fertil Steril 58, 396-402 (1992).
35. R. J. Naz. Role of membrane tyrosine kinases in human sperm function. In: Human Sperm Acrosome Reaction. Eds: Fenichel P, Parinaud J, Colloque INSERM/John Libbey Eurotext Ltd., Collioure, France, 245-255 (1995).
36. C. S. Melendrez & S. Meizel: Studies of porcine and human sperm suggesting a role for a sperm glycine receptor/Cl- channel in the zona pellucida-initiated acrosome reaction. Biol Reprod 53, 676-683 (1995).
37. R. Yanagimachi. Mammalian Fertilization. In: The Physiology of Reproduction. Eds: Knobil E, Neill JD, Raven Press, New York, 189-317 (1994).
38. A. I. Yudin, W. Gottleib & S. Meizel: Ultrastructural studies of the early events of the Human sperm acrosome reaction as initiated by human follicular fluid. Gamete Res 20, 11-24 (1988).
39. D. J. Miller, X. Gong & B. D. Shur: Sperm require beta-N-acetylglucosaminidase to penetrate through the egg zona pellucida. Development 118, 1279-89 (1993).
40. C. R. Stauss, T. J. Votta & S. S. Suarez: Sperm motility hyperactivation facilitates penetration of the hamster zona pellucida. Biol Reprod 53, 1280-1285 (1995).
41. M. N. Llanos, P. Morales & M. S. Riffo: Studies of lysophospholipids related to the hamster sperm acrosome reaction in vitro. J Exp Zool 267, 209-216 (1993).
42. M. N. Llanos, P. Morales, A. M. Salgado & P. Vigil. Effect of lysophospholipids on the human sperm acrosome reaction. In: Human Sperm Acrosome Reaction. Eds: Fenichel P, Parinaud J, Colloque INSERM/John Libbey Eurotext Ltd, Collioure, France, 410-411 (1995).
43. J. J. Parrish, J. L. Susko-Parrish, M. A. Winer & N. L. First: Capacitation of bovine sperm by heparine. Biol Reprod 38, 1171-1180 (1988).
44. J. Tesarik: Comparison of acrosome reaction-inducing activities of human cumulus oophorus, follicular fluid and ionophore A23187 in human sperm populations of proven fertilizing ability in vitro. J Reprod Fert 74, 383-388 (1985). 45. N. L. Cross, P. Morales, J. W. Overstreet & F. W. Hanson: Induction of the acrosome reaction by human zona pellucida. Biol Reprod 38, 235-244 (1988).
46. R. A. Osman, M. Andria, A. Jones & S. Meizel: Steroid induced exocytosis: the human sperm acrosome reaction. Biochem Biophys Res Commun 160, 828-833 (1989).
47. J. E. Siiteri, P. Dandekar & S. Meizel: Human sperm acrosome reaction-initiating activity associated with the human cumulus oophorus and mural granulosa cells. J Exp Zool 246, 71- (1988).
48. P. Morales, M. Llanos, G. Gutierrez, P. Kohen, P. Vigil & D. Vantman: The acrosome reaction inducing activity of individual human follicular fluid samples is highly variable and is related to the steroid content. Hum Reprod 7, 646-651 (1992).
49. S. Meizel, M. C. Pillai, E. Díaz-Pérez & P. Thomas. Initiation of the human sperm acrosome reaction by components of human follicular fluid and cumulus secretions including steroids. In: Fertilization in Mammals. Eds: Bavister BD, Cummins J, Roldan ERS, Serono Symposia, Norwell, Massachusetts, 205-222 (1990).
50. E. Baldi, C. Krausz & G. Forti: Nongenomic actions of progesterone on human spermatozoa. Trends in Endocrinol Metab 6, 198-205 (1995).
51. S. Meizel. Initiation of Human sperm acrosome reaction by progesterone. In: Human Sperm Acrosome Reaction. Eds: Fenichel P, Parinaud J, Colloque INSERM/John Libbey Eurotext Ltd, Collioure, France, 151-164 (1995).
52. P. F. Blackmore & F. A. Lattanzio: Cell surface localization of a novel non-genomic progesterone receptor on the head of human sperm. Biochem Biophys Res Commun 181, 331-6 (1991).
53. J. Tesarik, C. Mendoza, J. Moos & A. Carreras: Selective expression of a progesterone receptor on the human sperm surface. Fertil Steril 58, 784-792 (1992).
54. P. Blackmore, S. J. Beebe, D. R. Danforth & N. Alexander: Progesterone and 17a-hydroxyproges-terone. Novel stimulators of calcium influx in human sperm. J Biol Chem 265, 1376-1380 (1990).
55. P. Thomas & S. Meizel: An influx of extracellular calcium is required for initiation of the human sperm acrosome reaction induced by human follicular fluid. Gamete Res 20, 397-411 (1988).
56. C. Foresta, M. Rossato & F. Di Virgilio: Differential modulation by protein kinase C of progesterone-activated responses in human sperm. Biochem Biophys Res Commun 206, 408-13 (1995).
57. K. O. Turner & S. Meizel: Progesterone-mediated efflux of cytosolic chloride during the Human sperm acrosome reaction. Biochem Biophys Res Commun 213, 774-780 (1995).
58. C. A. Wistrom & S. Meizel: Evidence suggesting involvement of a unique human sperm steroid receptor/Cl- channel complex in the progesterone-initiated acrosome reaction. Dev Biol 159, 679-90 (1993).
59. M. Luconi, L. Bonaccorsi, C. Krausz, G. Gervasi, G. Forti & E. Baldi: Stimulation of protein tyrosin phosphorylation by platelet-activating factor and progesterone in human spermatozoa. Mol Cell Endocrinol 108, 35-42 (1995).
60. J. Tesarik, J. Moos & C. Mendoza: Stimulation of protein tyrosine phosphorylation by a progesterone receptor on the cell surface of human sperm. Endocrinology 133, 328-335 (1993).
61. C. Mendoza, A. Soler & J. Tesarik: Nongenomic steroid action: independent targeting of a plasma membrane calcium channel and a tyrosine kinase. Biochem Biophys Res Commun 210, 518-23 (1995).
62. H. Florman M & B. T. Storey: Mouse gamete interactions: the zona pellucida is the site of the acrosome reaction leading to fertilization in vitro. Dev Biol 91, 121-130 (1982).
63. F. B. Kuzan, A. D. Fleming & G. E. Seidel: Successful fertilization in vitro of fresh intact oocytes by periviteline (acrosome-reacted) spermatozoa of the rabbit. Fertil Steril 41, 766-770 (1984).
64. D. G. Myles, H. Hyatt & P. Primakoff: Binding of both acrosome-intact and acrosome-reacted guinea pig sperm to the zona pellucida during in vitro fertilization. Dev Biol 121, 559-567 (1987).
65. P. Morales, N. L. Cross, J. W. Overstreet & F. W. Hanson: Acrosome intact and acrosome reacted human sperm can initiate binding to the zona pellucida. Dev Biol 133, 385-392 (1989).
66. M. van Duin, J. E. M. Polman, I. T. M. Debreet, K. Vanginneken, H. Bunschoten, A. Grootenhuis, J. Brindle & R. J. Aitken: Recombinant human zona pellucida protein ZP3 produced by chinese hamster ovary cells induces the human sperm acrosome reaction and promotes sperm-egg fusion. Biol Reprod 51, 607-17 (1994).
67. M. H. Vazquez, D. M. Phillips & P. M. Wassarman: Interaction of mouse sperm with purified sperm receptor covalently linked to silica beads. J Cell Sci 92, 713-722 (1989).
68. M. A. Lee, J. H. Check & G. S. Kopf: A guanine nucleotide-binding regulatory protein in human sperm mediates acrosomal exocytosis induced by the human zona pellucida. Mol Reprod Dev 31, 78-86 (1992).
69. D. R. Franken, P. Morales & U.-F. Habenicht: Inhibition of G-protein in human sperm and its influence on acrosome reaction and zona pellucida binding. Fertil Steril (in press), (1996).
70. Y. Endo, M. A. Lee & G. S. Kopf: Evidence for a role of a guanine nucleotide-binding regulatory protein in the zona pellucida- induced mouse sperm acrosome reaction. Dev Biol 119, 210-216 (1987).
71. H. M. Florman, R. M. Tombes, N. L. First & D. F. Babcock: An adhesion-associated agonist from the zona pellucida activates G-protein promoted elevation in Ca2+ and pH that mediate mammalian sperm acrosomal exocytosis. Dev Biol 135, 133-146 (1989).
72. A. Spiegel, A. Carter, M. Brann, R. Collins, P. Goldsmith, W. Simonds, R. Vinitsky, B. Eide, K. Rossiter, L. Weinstein & C. Woodard: Signal transduction by guanine nucleotide binding protein. Rec Prog Horm Res 44, 337-375 (1988).
73. C. R. Ward & G. S. Kopf: Molecular event mediating sperm activation. Dev Biol 158, 9-34 (1993).
74. B. T. Storey, C. L. Hourani & J. B. Kim: A transient rise in intracellular Ca2+ is a precursor reaction to the zona-pellucida-induced acrosome reaction in mouse sperm and is blocked by the induced acrosome reaction inhibitor 3-quinuclidinyl benzilate. Mol Reprod Dev 32, 41-50 (1992).
75. Y. Endo, M. Lee & G. S. Kopf: Characterization of an islet-activating protein-sensitive site in mouse sperm that is involved in the zona pellucida-induced acrosome reaction. Dev Biol 129, 12-24 (1988).
76. H. M. Florman, J. R. Lemos, C. Arnoult, J. A. Oberdof & Y. Zeng. Exo (cyto) tic ion channels in mammalian sperm. In: Human Sperm Acrosome Reaction. Eds: Fenichel P, Parinaud J, Colloque INSERM/John Libbey Eurotext Ltd., Collioure, France, 179-189 (1995).
77. J. Lytton, M. Westlin & M. R. Hanley: Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca2+ ATP family of calcium pumps. J Biol Chem 266, 17067-17071 (1991).
78. O. Thastrup, P. Cullen, B. Drobak, M. Hanley & A. Dawson: Thapsigargin, a tumor promoter, discharges intracellular Ca2+ store by specific inhibition of the endoplasmic reticulum Ca2+-ATPase. Proc Natl Acad Sci USA 87, 2466-2470 (1990).
79. S. Meizel & K. O. Turner: Initiation of the Human sperm acrosome reaction by thapsigargin. J Exp Zool 267, 350-355 (1993).
80. L. D. Walensky & S. H. Snyder: Inositol 1,4,5-trisphosphate receptors selectively localized to the acrosomes of mammalian sperm. J Cell Biol 130, 857-869 (1995).
81. M. N. Llanos: Thapsigargin stimulates the hamster sperm acrosome reaction. Biol Reprod in press, (1996). 82. R. A. P. Harrison & E. R. S. Roldan: Phosphoinositides and their products in the mammalian sperm acrosome reaction. J Reprod Fert 42, 51-67 (1990).
83. E. R. S. Roldan & F. Mollinedo: Diacylglycerol stimulates the Ca2+-dependent phospholipase A2 on ram spermatozoa. Biochem Biophys Res Commun 176, 294-300 (1991).
84. E. R. S. Roldan & T. Murase: Polyphosphoinositide-derived diacylglycerol stimu-lates the hydrolysis of phosphatidylcholine by phospholipase C during exocytosis of the ram sperm acrosome. J Biol Chem 269, 23583-23589 (1994).
85. G. Berruti & M. Franchi: Calcium and polyphosphoinositides: the distribution in relation to the membrane changes occurring in the head of boar spermatozoa. Eur J Cell Biol 41, 238-245 (1986).
86. I. Nishizuka: Intracellular signaling by hydrolysis, phospholipids, and activation of protein kinase C. Science 258, 607-614 (1992).
87. H. Breibart, J. Lax, R. Rotem & Z. Naor: Role of protein kinase C in the acrosome reaction of mammalian spermatozoa. Biochem J 281, 473-476 (1992).
88. Z. Naor, R. Rotem & M. Kalina. Role of protein kinase C in human sperm acrosome reaction. In: Human Sperm Acrosome Reaction. Eds: Fenichel P, Parinaud J, Colloque INSERM/John Libbey Eurotext Ltd., Collioure, France, 217-223 (1995).
89. E. R. S. Roldan & C. Fragio: Phospholipase A2 activation and subsequent exocytosis in the Ca2+-ionophore-induced acrosome reaction of ram spermatozoa. J Biol Chem 268, 13962-13970 (1993).
90. C. N. Tomes, C. R. McMaster & P. M. Saling: Activation of mouse sperm phosphatidylinositol-4,5 bisphosphate-phospholipase C by zona pellucida is modulated by tyrosine phosphorylation. Mol Reprod Dev 43, 196-204 (1996).
91. P. Thomas & S. Meizel: Phosphatidylinositol 4,5-biphosphate hydrolysis in human sperm stimulated with follicular fluid or progesterone is dependent upon Ca++ influx. Biochem J 264, 539-546 (1989).
92. E. R. S. Roldan & R. A. P. Harrison: Diacylglycerol in the exocytosis of the mammalian sperm acrosome. Biochem Soc Trans, 21, 284-289 (1993).
93. C. J. De Jonge, H. L. Han, H. Lawrie, S. R. Mack & L. J. D. Zaneveld: Modulation of the human sperm acrosome reaction by effectors of the adenylate/cyclic AMP second-messenger pathway. J Exp Zool 258, 113-125 (1991).
94. C. De Jonge. Role of cAMP pathway: cross-talk mechanisms for the acrosome reaction. In: Human Sperm Acrosome Reaction. Eds: Fenichel P, Parinaud J, Colloque INSERM/John Libbey Eurotext Ltd., Collioure, France, 257-276 (1995).
95. T. D. Noland, D. L. Garbers & G. S. Kopf: An elevation in cAMP concentration precedes the zona pellucida-induced acrosome reaction of mouse sperm. Biol Reprod 38 (Suppl 1), 138 (1988).
96. P. Lecler & G. S. Kopf: Mouse sperm adenylyl cyclase: general properties and regulation by the zona pellucida. Biol Reprod 52, 1227-1233 (1995).
97. G. S. Kopf, M. J. Woolkalis & G. L. Gerton: Evidence for a guanine nucleotide-binding regulatory protein in invertebrates and mammalian sperm. Identification by islet-activating protein-catalyzed ADP ribosylation and immunochemical methods. J Biol Chem 261, 7327-7331 (1986).
98. L. Leyton, P. LeGuen, D. Bunch & P. M. Saling: Regulation of mouse gamete interaction by a sperm tyrosine kinase. Proc Natl Acad Sci USA 89, 11692-11695 (1992).
99. P. Saling: How the egg regulates sperm function during gamete interaction: facts and fantasies. Biol Reprod 44, 246-251 (1991).
100. P. Morales, T. Socias, J. Cortez & M. N. Llanos: Evidences for the presence of a chymotrypsin-like activity in human spermatozoa with a role in the acrosome reaction. Mol Reprod Dev 38, 222-230 (1994).
101. J. E. Dravland, M. N. Llanos, R. J. Munn & S. Meizel: Evidence for the involvement of a trypsinlike enzyme in the membrane events of the hamster sperm acrosome reaction. J Exp Zool 232, 117-128 (1984).
102. G. Shams-Borhan & R. A. P. Harrison: Production, characterization, and use of ionophore-induced, calcium-dependent acrosome reaction in ram spermatozoa. Gamete Res 4, 407-432 (1981).
103. M. Llanos, P. Vigil, A. M. Salgado & P. Morales: Inhibition of the acrosome reaction by trypsin inhibitors and prevention of penetration of spermatozoa through the human zona pellucida. J Reprod Fert 97, 173-8 (1993).
104. K. Matsumura & K. Aketa: Activation of Ca2+ channels during the acrosome reaction of sea urchin sperm is inhibited by inhibitors of chymotrypsin-like proteases. Gamete Res 23, 255-266 (1989).
105. M. Llanos, P. Morales & S. Meizel: Evidences for a role of a chymotrypsin-like activity in the increase in intracellular calcium required for the human sperm acrosome reaction. Noticiero de Biología 3, 58P (1995).
106. M. C. Pillai & S. Meizel: Trypsin inhibitors prevent the progesterone-initiated increase in intracellular calcium required for the human sperm acrosome reaction. J Exp Zool 258, 384-393 (1991).
107. Y. Lin, K. Mahan, W. F. Lathrop, D. G. Myles & P. Primakoff: A hyaluronidase activity of the sperm plasma membrane protein PH-20 enables sperm to penetrate the cumulus cell layer surrounding the egg. J Cell Biol 125, 1157-63 (1994).
108. S. Meizel & K. O. Turner: Progesterone acts at the plasma membrane of human sperm. Mol Cell Endocrinol 11, R1-R5 (1991).
109. J. Tesarik, A. Carreras & C. Mendoza: Differential sensitivity of progesterone- and zona pellucida-induced acrosome reactions to pertussis toxin. Mol Reprod Dev 34, 183-189 (1993).
110. E. R. S. Roldan, T. Murase & Q.-X. Shi: Exocytosis in spermatozoa in response to progesterone and zona pellucida. Science 266, 1578-1581 (1994).
111. C. E. Sueldo, S. Oehninger, E. Subias, M. Mahony, N. J. Alexander, L. J. Burkman & A. A. Acosta: Effect of progesterone on human zona pellucida sperm binding and oocyte penetrating capacity. Fertil Steril 60, 137-40 (1993).
112. S. Oehninger, C. Sueldo, S. Lanzendorf, M. Mahony, L. J. Burkman, N. J. Alexander & G. D. Hodgen: A sequential analysis of the effect of progesterone on specific sperm functions crucial to fertilization in vitro in infertile patients. Hum Reprod 9, 1322-1327 (1994).
113. S. Oehninger, A. A. Acosta, M. Morshedi, L. Veeck, R. J. Swanson, K. F. Simmons & Z. Rosenwaks: Corrective measures and pregnancy outcome in in vitro fertilization in patients with severe sperm morphology abnormalities. Fertil Steril 50, 283-287 (1988).
114. B. Lassalle & J. Testart: Human zona pellucida recognition associated with removal of sialic acid from human sperm surface. J Reprod Fert 101, 703-11 (1994).
115. A. Rosado, A. Velazquez & R. Lara-Ricalde: Cell Polarography. II. Effect of neuraminidase and follicular fluid upon the surface characteristics of human spermatozoa. Fertil Steril 24, 349-354 (1973).
116. P. N. Srivastava & A. A. Farooqui: Studies on neuraminidase activity of the rabbit endometrium. J Exp Zool 245, 106-110. (1988).
117. J. S. Chen, G. F. Doncel, C. Alvarez & A. A. Acosta: Expression of mannose-binding sites on human spermatozoa and their role in sperm-zona pellucida binding. J Androl 16, 55-63 (1995).
118. S. Oehninger, G. F. Clark, A. A. Acosta & G. D. Hodgen: Nature of the inhibitory effect of complex saccharide moieties on the tight binding of human spermatozoa to the human zona pellucida. Fertil Steril 55, 165-169 (1991).
119. R. Jones: Unusual fucoidin-binding properties of chymotrypsinogen and trypsinogen. Biochim Biophys Acta 1037, 227-232 (1990).
120. S. Francavilla, A. Gabriele, R. Romano, L. Gianaroli, A. P. Ferraretti & F. Francavilla: Sperm-zona pellucida binding of human sperm is correlated with the immunocytochemical presence of proacrosin and acrosin in the sperm head but not with the proteolytic activity of acrosin. Fertil Steril 62, 1226-1233 (1994).
121. R. A. Anderson, C. Oswald, S. Leto & L. J. D. Zaneveld: Inhibition of human acrosin by fructose and other monosaccharides. Biol Reprod 22, 1079-1082 (1980).
122. D. Barisic, M. J. Scobey, D. E. Johnson & R. S. Jeyendran: The effect of preincubation of human spermatozoa in milk on sperm penetration into zona-free hamster oocytes and on sperm binding to the human zona pellucida. Fertil Steril 62, 172-5 (1994).
123. S. E. Lanzendorf, W. J. Holmgren & R. S. Jeyendran: The effect of egg yolk medium on human sperm binding in the hemizona assay. Fertil Steril 58, 547-50 (1992).
124. S. Oehninger, C. C. Coddington, G. D. Hodgen & M. Seppala: Factors affecting fertilization: endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida. Fertil Steril 63, 377-83 (1995).
125. F. J. Cornillie, J. M. Lauweryns, M. Seppala, L. Riittinen & P. R. Koninckx: Expression of endometrial protein PP14 in pelvic and ovarian endometriotic implants. Hum Reprod 6, 1411-1415 (1991).
126. P. Morales, R. Riquelme, A. M. Salgado, A. Umaña & L. Leiva: Effect of GnRH upon sperm ability to bind to the human zona pellucida (hZP). Biol Reprod 50, 147P (1994).
127. C. Oliva, L. Lara, F. Labra, P. Vigil & P. Morales. El antagonista de GnRH, [Ac- 3-Pro1, pF-D-Phe2, D-Trp3,6]-LHRH, inhibe la unión de los espermatozoides a la zona pelúcida humana (hZP). XIV Reunión ALIRH. Santo Domingo, República Dominicana: , 1995: R-130.
128. S.-Y. Ying, N. Ling, P. Bohlen & R. Guillemin: Gonadocrinins: peptides in ovarian follicular fluid stimulating the secretion of pituitary gonadotropins. Endocrinology 108, 1206-1215 (1981).
129. S.-I. Izumi, T. Makino & R. Iizuka: Immunoreactive luteinizing hormone-releasing hormone in the seminal plasma and human semen parameters. Fertil Steril 43, 617-620 (1985).
130. R. Z. Sokol, M. Peterson, D. Heber & R. S. Swerdloff: Identification and partial characterization of gonadotropin-releasing hormone-like factors in human seminal plasma. Biol Reprod 33, 370-374 (1985).
131. R. F. Aten, J. J. Ireland, C. W. Weems & H. R. Behrman: Presence of gonadotropin-releasing hormone-like proteins in bovine and ovine ovaries. Endocrinology 120, 1727-1733 (1987).
132. W. I. Li, S. Jiao & P. P. Chin: Immunoreactive gonadotropin-releasing hormone in porcine reproductive tissues. Peptides 14, 543-549 (1993).
133. M. Oikawa, C. Dargan, T. Ny & A. J. Hsueh: Expression of gonadotropin-releasing hormone and prothymosin-alpha messenger ribonucleic acid in the ovary. Endocrinology 127, 2350-2356 (1990).
134. R. M. Sharpe & I. Cooper: Comparison of the effects on purified Leydig cells of four hormones (oxytocin, vasopressin, opiates and LHRH) with suggested paracrine roles in the testis. J Endocrinol 113, 89-96 (1987).
135. N. Azad, S. Uddin, N. La Paglia, L. Kirsteins, N. V. Emanuele, A. M. Lawrence & M. R. Kelley: Luteinizing hormone-releasing hormone (LHRH) in rat prostate: characterization of LHRH peptide, messenger ribonucleic acid expression, and molecular processing of LHRH in intact and castrated male rats. Endocrinology 133, 1252-1257 (1993).
136. M. P. Hedger, D. M. Robertson, C. A. Browne & D. de Kretser: The isolation and measurement of luteinizing hormone-releasing hormone (LHRH) from the rat testis. Mol Cell Endocrinol 42, 163-74 (1985).
137. A. J. Hsueh & J. M. Schaeffer: Gonadotropin-releasing hormone as a paracrine hormone and neurotransmitter in extra-pituitary sites. J Steroid Biochem 23, 757-64 (1985).
138. P. P. Saint, E. Hermand & G. Tramu: Paracrine factors in adult rat testis gonadotrophin control of opioids and LHRH like peptide. Andrologia 20, 173-181 (1988).
139. G. Verhoeven & J. Cailleau: A factor in spent media from Sertoli-cell-enriched cultures that stimulates steroidogenesis in Leydig cells. Mol Cell Endocrinol 40, 57-68 (1985).